The increasing frequency of cervical cancer in Korean women under 35.
OBJECTIVE
The goal of this study was to determine the clinical and epidemiological trends of cervical cancer in young Korean women. Social behavior including sexual habits has changed in Korean women, with sexual activity commencing at a younger age. These changes are likely to influence certain risk factors of cervical cancer, resulting in changing trends in the occurrence of the disease.


METHODS
The incidence of cervical cancer in women less than 35 years-old between January 1990 and December 2006 was analyzed, and available medical records from January 1996 to December 2006 were reviewed. The clinical, pathological and epidemiologic characteristics and changing trends among these young patients were analyzed.


RESULTS
Over the last two decades, the incidence of young (< 35 years) cervical cancer patients increased, more patients had an aggressive form of the disease, and there was a higher rate of women with more advanced education. Human papillomavirus (HPV) infection was detected in 94.0% of the women (63/67) tested. HPV 16 (82.5%) and HPV 18 (12.7%) were the two most common viral infections detected throughout the study period.


CONCLUSIONS
The changing trends and risk factors identified suggest a need for more active education of young women about cervical cancer prevention strategies. In addition, young women are strongly recommended to undergo a regular screening test and HPV vaccination.
Han
Chan Hee
CH
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Cho
Hyun Jung
HJ
Lee
Sung Jong
SJ
Bae
Jeong Hoon
JH
Bae
Seog Nyen
SN
Namkoong
Sung Eun
SE
Park
Jong Sup
JS
DNA Cell Biol. 2004 Feb;23(2):119-25
15000752
Int J Gynecol Cancer. 2007 Jul-Aug;17(4):833-42
17367320
Lancet. 2006 Nov 11;368(9548):1706-28
17098090
BMJ. 1989 Feb 4;298(6669):288-90
2493898
Gynecol Oncol. 2007 Feb;104(2):372-6
17030353
J Microbiol Biotechnol. 2008 Apr;18(4):788-94
18467878
Am J Med. 1997 May 5;102(5A):3-8
9217656
Clin Oncol (R Coll Radiol). 1990 Sep;2(5):260-3
2261425
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
15761078
Int J Gynaecol Obstet. 1993 Apr;41(1):61-6
8098297
J Microbiol. 2004 Dec;42(4):255-66
15650698
Int J Gynaecol Obstet. 2006 Nov;95 Suppl 1:S43-S103
29644676
J Prev Med Public Health. 2005 Nov;38(4):473-81
16358835
Int J Cancer. 2007 Feb 15;120(4):885-91
17131323
Int J Cancer. 2003 Jan 20;103(3):413-21
12471626
Cytopathology. 2006 Aug;17(4):187-94
16879266
JAMA. 1994 Apr 20;271(15):1181-8
8151876
Virology. 2005 Jun 20;337(1):76-84
15914222
Int J Gynecol Cancer. 2006 Sep-Oct;16(5):1833-8
17009979
Cancer Surv. 1994;19-20:519-61
7534640
Int J Gynaecol Obstet. 2003 Sep;82(3):369-79
14499983
Br Med J (Clin Res Ed). 1987 Aug 1;295(6593):300-3
3115418
BMC Cancer. 2007 Aug 23;7:164
17718897